First National Bank of Omaha Buys New Shares in Integer Holdings Corporation $ITGR

First National Bank of Omaha acquired a new stake in Integer Holdings Corporation (NYSE:ITGR) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 18,460 shares of the medical equipment provider’s stock, valued at approximately $1,725,000.

Several other institutional investors and hedge funds have also bought and sold shares of ITGR. Salomon & Ludwin LLC boosted its position in shares of Integer by 46.8% during the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 118 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Integer by 48.1% during the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock valued at $32,000 after buying an additional 117 shares during the last quarter. TD Private Client Wealth LLC grew its stake in shares of Integer by 1,037.5% in the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 415 shares in the last quarter. Parkside Financial Bank & Trust grew its position in Integer by 135.5% in the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 267 shares in the last quarter. Finally, Arax Advisory Partners grew its holdings in shares of Integer by 2,489.5% in the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 473 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

Analyst Ratings Changes

ITGR has been the subject of a number of research analyst reports. HC Wainwright restated a “buy” rating on shares of Integer in a report on Friday, July 24th. Wells Fargo & Company boosted their price objective on Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Integer in a research note on Thursday, June 18th. Freedom Capital downgraded Integer from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 4th. Finally, Benchmark cut shares of Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th. One investment analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $109.86.

Integer Stock Up 0.2%

ITGR opened at $125.29 on Thursday. The business’s fifty day simple moving average is $102.77 and its 200 day simple moving average is $92.60. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $126.14. The company has a quick ratio of 2.41, a current ratio of 3.73 and a debt-to-equity ratio of 0.75. The stock has a market cap of $4.26 billion, a PE ratio of 34.23, a P/E/G ratio of 2.96 and a beta of 0.61.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The firm had revenue of $464.11 million during the quarter, compared to analyst estimates of $451.07 million. During the same quarter in the previous year, the company posted $1.55 earnings per share. The company’s revenue was down 2.6% compared to the same quarter last year. As a group, research analysts expect that Integer Holdings Corporation will post 6.08 earnings per share for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.